Cargando…
Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device
Islet transplantation is a successful β-cell replacement therapy for selected patients with type 1 diabetes mellitus. Although high rates of early insulin independence are achieved routinely, long-term function wanes over time. Intraportal transplantation is associated with procedural risks, require...
Autores principales: | Pepper, Andrew R., Pawlick, Rena, Gala-Lopez, Boris, MacGillivary, Amanda, Mazzuca, Delfina M., White, David J. G., Toleikis, Philip M., Shapiro, A. M. James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623852/ https://www.ncbi.nlm.nih.gov/pubmed/26308506 http://dx.doi.org/10.1097/TP.0000000000000864 |
Ejemplares similares
-
Glutathione Ethyl Ester Supplementation during Pancreatic Islet Isolation Improves Viability and Transplant Outcomes in a Murine Marginal Islet Mass Model
por: Raposo do Amaral, Alexandre S., et al.
Publicado: (2013) -
Subcutaneous transplantation of human thyroid tissue into a pre-vascularized Cell Pouch™ device in a Mus musculus model: Evidence of viability and function for thyroid transplantation
por: Wiseman, Sam M., et al.
Publicado: (2022) -
Lung-Derived Microscaffolds Facilitate Diabetes Reversal after Mouse and Human Intraperitoneal Islet Transplantation
por: Abualhassan, Nasser, et al.
Publicado: (2016) -
Ferroptosis-inducing agents compromise in vitro human islet viability and function
por: Bruni, Antonio, et al.
Publicado: (2018) -
Improved islet recovery and efficacy through co-culture and co-transplantation of islets with human adipose-derived mesenchymal stem cells
por: Gamble, Anissa, et al.
Publicado: (2018)